Mountain Lakes, NJ, United States of America

Bruce Jay Simon

This inventor holds 159 USPTO granted patents and 47 published patent applications and 11 EPO patents, primarily in Nerve Stimulation (CPC class A61N1-0456). Top assignees: Electrocore, Inc., Ebi, LLC, Biomet Biologics, LLC. Active years: 2001-2026.

USPTO Granted Patents = 159 

% Patents Active = 88.1

 

Average Co-Inventor Count = 2.6

ph-index = 36

Forward Citations = 3,128(Granted Patents)

Forward Citations (Not Self Cited) = 2,710(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Mountian Lakes, NJ (US) (2016)
  • Mountain Lakes, NJ (US) (2001 - 2024)
  • Santa Fe, NM (US) (2023 - 2024)

Company Filing History:


Years Active: 2001-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Nerve Stimulation
Vagal Nerve Stimulation
Remote Therapy
Non-Invasive Treatments
Electrical Stimulation
Mobile Device Applications
Patient Monitoring
Medical Disorders
Dopamine-Related Conditions
Post-Traumatic Stress Disorder
Gastroparesis Treatment
Development Disorders
159 patents (USPTO):Explore Patents

Title: Bruce Jay Simon: Pioneering Non-Invasive Nerve Stimulation Innovator

Introduction:

Bruce Jay Simon, a resident of Mountain Lakes, NJ, is a highly accomplished inventor and patent holder with a remarkable portfolio of 134 patents. Known for his groundbreaking work in non-invasive nerve stimulation, Simon has dedicated his career to developing devices, systems, and methods aimed at improving the treatment of various medical conditions. This article explores Simon's latest patents, career highlights, notable collaborations, and underscores his significant contributions to the field of medical innovations.

Latest Patents:

One of Simon's recent patents is the development of a nerve stimulator specifically designed for use with a mobile device. This ground-breaking invention allows for the treatment of seizures, such as epileptic seizures, through electrical non-invasive stimulation of the vagus nerve. The stimulator, equipped with an electrode for contacting the patient's outer skin surface, can transmit electrical impulses through the skin, directly modulating the targeted nerve, and alleviating seizure symptoms.

Another remarkable patent Simon holds is the non-invasive nerve stimulation system. This invention provides an alternative approach to treat various disorders and medical conditions by stimulating a selected nerve through an electrode that comes into contact with the patient's outer skin surface. The system also includes an application on a mobile device that facilitates communication with the stimulator, allowing for seamless data transmission and monitoring.

Career Highlights:

Bruce Jay Simon's career is closely intertwined with his work at ElectroCore, Inc., a leading medical technology company specializing in non-invasive vagus nerve stimulation therapies. During his tenure at ElectroCore, Simon made significant contributions to the development of cutting-edge devices and systems aimed at transforming medical treatments.

Collaborations:

Simon has collaborated with esteemed coworkers throughout his career. Two notable names include Joseph P Errico and John T Raffle. These collaborations have fueled innovation, pushing the boundaries of non-invasive nerve stimulation technology.

Conclusion:

Bruce Jay Simon is a visionary inventor and patent holder whose groundbreaking contributions in the field of non-invasive nerve stimulation have the potential to revolutionize medical treatments. His patents, such as the nerve stimulator for mobile devices and non-invasive nerve stimulation system, showcase his dedication to improving patient care and quality of life. Collaborating with esteemed professionals, Simon has solidified his position as a pivotal figure in the world of medical innovation. Through his remarkable career, Simon continues to leave a lasting impact on the field and shape the future of medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…